
This study aimed to investigate if plasma levels of heparan sulphate (HS) are associated with the aetiology of AECOPD. Plasma HS was higher in patients with COPD compared to non‐COPD and was significantly increased at AECOPD compared to a stable state in the discovery and validation cohorts. The results indicate that circulating levels of HS are increased at AECOPD, which may be associated with the aetiology of these events.
Like
Save
Share